cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · IEX Real-Time Price · USD
0.600
-0.020 (-3.19%)
At close: Jul 19, 2024, 4:00 PM
0.530
-0.070 (-11.66%)
After-hours: Jul 20, 2024, 12:57 PM EDT
cbdMD Revenue
cbdMD had revenue of $21.58M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $4.38M. In the fiscal year ending September 30, 2023, cbdMD had annual revenue of $24.16M.
Revenue (ttm)
$21.58M
Revenue Growth
-25.00%
P/S Ratio
0.11
Revenue / Employee
$415,039
Employees
52
Market Cap
2.32M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2023 | 24.16M | -11.25M | -31.77% |
Sep 30, 2022 | 35.40M | -9.08M | -20.41% |
Sep 30, 2021 | 44.48M | 2.60M | 6.20% |
Sep 30, 2020 | 41.88M | 18.23M | 77.09% |
Sep 30, 2019 | 23.65M | 23.19M | 5,051.82% |
Sep 30, 2018 | 459.09K | -4.02M | -89.74% |
Sep 30, 2017 | 4.47M | 2.44M | 120.27% |
Sep 30, 2016 | 2.03M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
NovaBay Pharmaceuticals | 14.23M |
InMed Pharmaceuticals | 5.63M |
NanoVibronix | 2.85M |
Tivic Health Systems | 1.13M |
Catheter Precision | 439.00K |
Aclarion | 60.05K |
Heart Test Laboratories | 18.60K |
YCBD News
- 24 days ago - cbdMD Announces Publication of Human Clinical Trial Data - Newsfile Corp
- 6 weeks ago - cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards - Newsfile Corp
- 2 months ago - cbdMD Unveils ATRx Labs Premium Mushroom Line at GNC, Expanding cbdMD's Natural Wellness Solutions - Newsfile Corp
- 2 months ago - cbdMD Launches Max Chill Dragon Fruit D9 Gummies: Your Go-To Relaxation Blend for the Summer - Newsfile Corp
- 2 months ago - cbdMD Reports Second Quarter Results - Newsfile Corp
- 2 months ago - cbdMD, Inc. to Host Conference Call to Discuss Second Quarter of Fiscal 2024 Results - Newsfile Corp
- 5 months ago - cbdMD Reduces Year over Year Net Loss from Operations by $3.0 Million - Newsfile Corp
- 5 months ago - cbdMD, Inc. to Host Conference Call to Discuss First Quarter of Fiscal 2024 Results - Newsfile Corp